Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150202
Status:
COMPLETED
Last Update Posted:
2007-05-07
First Post:
2005-09-06
Brief Title:
Clinical Study Of EYE001 For Wet-Type AMD Age-Related Macular Degeneration
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Clinical Study Of EYE001 In Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
Status:
COMPLETED
Status Verified Date:
2006-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will examine the efficacy and safety of pegaptanib sodium in Japanese patients with wet-type AMD in order to establish that there is no large difference in the efficacy and the safety of the drug between Western and Japanese patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None